CELLESTIA

Welcome to the Brand page for “CELLESTIA”, which is offered here for Pharmaceutical and veterinary products, for the treatment of cancer and for regenerative medicine; pharmaceutical preparations for the treatment of cancer, leukemia, lymphoma, inflammatory diseases, liver diseases, lung diseases, cardio diseases, vascular diseases, genetic disorders and immunity disorders; pharmaceutical products, small molecule drugs for the treatment of cancer; pharmaceutical products for the treatment of notch-dependent cancers; medicinal preparations for the treatment of cancer, leukemia, lymphoma, inflammatory diseases, liver diseases, lung diseases, cardio diseases, vascular diseases, genetic disorders and immunity disorders; veterinary medicines for the treatment of cancer, leukemia, lymphoma, inflammatory diseases, liver diseases, lung diseases, cardio diseases, vascular diseases, genetic disorders and immunity disorders; chemical and pharmaceutical preparations for the treatment of cancer, leukemia, lymphoma, inflammatory diseases, liver diseases, lung diseases, cardio diseases, vascular diseases, genetic disorders and immunity disorders; diagnostic preparations for medical use; chemical and pharmaceutical preparations for veterinary use for the treatment of cancer, leukemia, lymphoma, inflammatory diseases, liver diseases, lung diseases, cardio diseases, vascular diseases, genetic disorders and immunity disorders;chemical products for use in industry and science, chemicals for use in the manufacture of pharmaceutical and veterinary products; chemicals for use in biotechnological product development;scientific and technological services, scientific research and development in the field of pharmaceuticals; research, development of products and quality control in the field of pharmacy; research in the field of chemistry and biology; industrial analysis and research services in the field of pharmaceuticals; research and development of pharmaceutical and veterinary products; chemical analysis and research in the field of pharmaceuticals;.

Its status is currently believed to be active. Its class is unavailable. “CELLESTIA” is believed to be currently owned by “Cellestia Biotech AG”.